Schedule 13D ownership disclosure

Merrimack Pharmaceuticals Inc

Security class unavailable · CUSIP: 590328209

Event date: 2020-11-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,519,107
Percent of class
11.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-20-001145
Form type
SC 13D/A
Filer
MERRIMACK PHARMACEUTICALS INC
CIK
CIK 1274792
Filed
Dec 02, 2020
Reporting period
Nov 24, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub